Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents

Author:

Papa Alessandro1,Cursaro Ilaria1ORCID,Pozzetti Luca1,Contri Chiara2,Cappello Martina2,Pasquini Silvia3ORCID,Carullo Gabriele1,Ramunno Anna4,Gemma Sandra1,Varani Katia2,Butini Stefania1ORCID,Campiani Giuseppe1,Vincenzi Fabrizio2

Affiliation:

1. Department of Biotechnology, Chemistry and Pharmacy University of Siena Siena Italy

2. Department of Translational Medicine University of Ferrara Ferrara Italy

3. Department of Chemical, Pharmaceutical and Agricultural Sciences University of Ferrara Ferrara Italy

4. Department of Pharmacy University of Salerno Fisciano Italy

Abstract

AbstractAiming to simultaneously modulate the endocannabinoid system (ECS) functions and the epigenetic machinery, we selected the fatty acid amide hydrolase (FAAH) and histone deacetylase (HDAC) enzymes as desired targets to develop potential neuroprotective multitarget‐directed ligands (MTDLs), expecting to achieve an additive or synergistic therapeutic effect in oxidative stress‐related conditions. We herein report the design, synthesis, and biological evaluation of the first‐in‐class FAAH‐HDAC multitarget inhibitors. A pharmacophore merging strategy was applied, yielding 1‐phenylpyrrole‐based compounds 4a–j. The best‐performing compounds (4c, 4f, and 4h) were tested for their neuroprotective properties in oxidative stress models, employing 1321N1 human astrocytoma cells and SHSY5 human neuronal cells. In our preliminary studies, compound 4h stood out, showing a balanced nanomolar inhibitory activity against the selected targets and outperforming the standard antioxidant N‐acetylcysteine in vitro. Together with 4f, 4h was also able to protect 1321N1 cells from tert‐butyl hydroperoxide or glutamate insult. Our study may provide the basis for the development of novel MTDLs targeting the ECS and epigenetic enzymes.

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3